Article Details

Roche's Lupus Study for Gazyva Meets Primary & Key Secondary Goals - Zacks

Retrieved on: 2024-09-26 14:33:22

Tags for this article:

Click the tags to see associated articles and topics

Roche's Lupus Study for Gazyva Meets Primary & Key Secondary Goals - Zacks. View article details on hiswai:

Excerpt

Please note that Roche's Gazyva/Gazyvaro has already been approved in 100 countries for various types of lymphoma. In the United States, Roche markets ...

Article found on: www.zacks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up